Moglobin, Albumin, Lymphocyte and Platelet Score as a Novel Predictor of Mortality and Re-bleeding in Patients With Upper Gastrointestinal Bleeding
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- "Mortality"
研究概览
简要总结
Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.
详细描述
Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
排除标准
- •Incomplete clinical data.
- •Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
- •Pregnancy
- •Patients with missing data on clinical outcomes
结局指标
主要结局
"Mortality"
时间窗: 6 months
Incidence of "Re_bleeding"
时间窗: 6 months
次要结局
未报告次要终点
研究者
Reham Refaat Baoumy
Resident doctor
Sohag University
